Fig. 5

Daunorubicin alters cell cycle profiles. Cell cycle profiles for MOLT-4 (a), CCRF-CEM (b) and SUP-B15 (c) cells following 4 h treatment with 10 μM daunorubicin followed by 4 h, 12 h and 24 h in recovery media. Graph indicates mean of total of six replicates ± SEM, from three independent experiments. * Results were normalised to the control at each time point. * P < 0.05, ** P < 0.01; *** P < 0.001; ns = non-significant one-way ANOVA followed by Tukey’s post-hoc test. Black G1 phase, Pink S phase and Blue G2/M phase